Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 2 of the last 4 fiscal years.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
-
Busy address KBO
86 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
Zoolyx from Aalst, company number BE0549932689, closed financial year 2025 with a result of € -751,778 after tax. For that financial year Zoolyx recorded revenue of € 6.2 million and equity of € -1.3 million. Compared with financial year 2024, the result moved from € -575,035 to € -751,778. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 1, 2026.
€ -1.3 million
▼ € 751,778 vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -751,778
▼ 31 % more loss than in 2024
Profit after tax over the fiscal year.
€ 14,559
▼ 90% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -1.3 million.
People and assets in 2025
46
▲ 1.1 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 2.3 million
▲ 8% vs 2024
€ 50,600 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 556,863
▼ 2% vs 2024
Of which on lease € 437,428.
Debts at end 2025
€ 2.8 million
▲ 5% vs 2024
€ 127,710 is repaid this year. At this pace the long-term loan is gone in ≈ 21 years.
€ 749,052
▲ 44% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 501,373
▲ 9% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Revenue | - | - | € 6,050,247 | € 6,197,545 | ▲ 2% |
| Gross margin | € 1,480,022 | € 1,538,941 | € 2,142,772 | € 2,369,268 | ▲ 11% |
| Profit after taxes | € 73,218 | € -325,035 | € -575,035 | € -751,778 | ▼ € 176,743 |
| Equity | € 371,821 | € 46,786 | € -528,249 | € -1,280,027 | ▼ € 751,778 |
| Total debts | € 978,414 | € 2,107,100 | € 3,722,623 | € 4,115,534 | ▲ 11% |
| Cash | € 49,100 | € 12,561 | € 145,417 | € 14,559 | ▼ 90% |
| Land & buildings | € 129,039 | - | - | € 140,467 | |
| Retained profit | € 309,821 | € -15,214 | € -590,249 | € -1,342,027 | ▼ € 751,778 |
| Bank debt | € 401,725 | € 1,063,784 | € 2,641,001 | € 2,769,183 | ▲ 5% |
| Balance sheet total | € 1,350,235 | € 2,153,886 | € 3,194,374 | € 2,835,507 | ▼ 11% |
| Employees (FTE) | - | 32.3 | 44.9 | 46 | ▲ 1.1 |
Key figures of Zoolyx, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Zoolyx?
What happened at Zoolyx in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- KAFINCO BV stepped down as director. NBB
- New annual accounts for financial year 2025: loss of € 751,778. Source: NBB ↗
- ECG Labs BV stepped down as director. NBB
- KAFINCO BV became a director. NBB
- New establishment in Lummen. KBO
- Tom Nagels became a director. NBB
- ECG Labs BV became a director. NBB
- New establishment in Aalst. KBO
In short
From € 73,218 profit in 2022 to € 751,778 loss in 2025.
Paid € 52,888 in corporate taxes since 2022.
Best year ever: 2022, with € 73,218 profit.
On average € 51,500 of value added per employee in 2025.
A new publication or filing at Zoolyx? We notify you, reason included.
Follow ZoolyxDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of ECG Labs comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
ZoolyxBehind Zoolyx is Tom Nagels. The shares are held by ECG Labs (100%).
Directors
According to the 2025 annual accounts
Tom Nagels
Director
since 2023
Director · represented by Jonathan Mommer
Also active at: ROOSE, Dierenartsenpraktijk Hendrikx - Deuss, WESTPAILLE, ECG Clinics, EQUINE CARE GROUP, EQUITOM LIEGE, REVERDY BENELUX, ECG Labs +4 more
since 2023 · until 2025
Director · represented by Julie Santens
Also active at: DESOTEC, ROOSE, D.E.S.O.T.E.C. INTERNATIONAL, David Bidco, ECG Labs, ECG Medical Care, ECG Nutrition and Supplements, ECG Ambulatory Care
since 2025 · until 2031
Shareholders
100%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Groeneweg 17
9320 Aalst
Bosstraat 54
3560 Lummen
Active since 1 January 2024
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 86 companies are registered at this address.
All companies at this address →CALDERS
€ 43,699 gross margin · 2023
SymphonyAI NetReveal Belgium
€ 31.3 million revenue · 2023
EVRARD CONSULTING
€ 28,150 gross margin · 2025
VTM Quality Services
€ 22.8 million revenue · 2025
AUGNITION
€ 1.6 million gross margin · 2025
+81 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0549.932.689
- VAT number
- BE 0549.932.689
- Registered office
- Groeneweg 17, 9320 Aalst
- Names & denominations
- Zoolyx
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 2 April 2014
- Peppol
- Active · Active since 15 Nov 2025
- Activities · NACE
Veterinaire diensten
Activiteiten van medische beeldvorming en medische laboratoria
Activiteiten van medische laboratoria